They are the same compound
How is 5-Amino-1MQ different from GLP-1 medications
Over time, BPC-157 has become the subject of extensivepreclinical investigation, particularly in laboratory and animal-based experimental models focused on tissue integrity, structural recovery mechanisms, and gastrointestinal physiology
preclinical safety evaluation found no genotoxicity, mutagenicity, or organ toxicity at tested doses
Peptide Vials (Tesamorelin, 10 mg each): 8 weeks 11 vials (105 mg total) 12 weeks 17 vials (161 mg total) 16 weeks 22 vials (217 mg total) Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Testing a single bottle only confirms that one unit